The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy
Author Information
Author(s): Aristo Vojdani, Jama Lambert, Gottfried Kellermann
Hypothesis
Can targeting Th17 and its inflammatory cytokine IL-17 provide effective therapeutic interventions for neuroimmune disorders?
Conclusion
The study suggests that understanding and manipulating the Th17 inflammatory pathway can lead to better treatment options for neuroimmune disorders.
Supporting Evidence
- Th17 cells play a pathogenic role in many inflammatory conditions.
- Healthcare providers have a variety of anti-inflammatory agents to choose from.
- Natural healing therapies are increasingly being sought after by patients.
Takeaway
This study talks about how a specific type of immune cell, Th17, can cause problems in diseases, and how we can use different treatments to help fix that.
Methodology
The review compiles various anti-inflammatory agents and discusses their mechanisms in targeting Th17 and IL-17 in neuroimmune disorders.
Potential Biases
Potential bias in the selection of studies and the interpretation of results may exist.
Limitations
The review is based on existing literature and does not present new experimental data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website